INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
GT

Girao Tiago

Chief Financial OfficerCIK 0001618670

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 3
Max Insider Score38
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
25
GT
Girao TiagoChief Financial Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$188K
6,606 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Immunovant, Inc.Chief Financial Officer · Apr 9, 2026
38
GT
Girao TiagoChief Financial Officer
IMVTImmunovant, Inc.
Open-market sale
SELL
$385K
10.0K sh
Jun 26, 2026
Jun 26, 2026
traded Jun 26, 2026
+0d
SEC FORM 4

Evidence

5
GT
Girao TiagoChief Financial Officer
IMVTImmunovant, Inc.
Option exercise
M—
10.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

8
GT
Girao TiagoChief Financial Officer
IMVTImmunovant, Inc.
Option exercise
M$159K
10.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

36
GT
Girao TiagoChief Financial Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$763K
25.8K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC FORM 4

Evidence

17
GT
Girao TiagoChief Financial Officer
IMVTImmunovant, Inc.
Grant or award
A—
65.0K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

9
GT
Girao TiagoChief Financial Officer
IMVTImmunovant, Inc.
Grant or award
A—
94.0K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence